Plasma Cell Disorders Meeting 2019
This is a clinically oriented lecture with the intention of allowing oncologists and other cancer health care providers to learn more about the biology and diagnostics of Plasma Cell Disorders and the latest innovations in treating them.
Hematological oncologists, clinical oncologists, and other cancer healthcare providers, including NPs, PAs, and RNs.
Following this program, participants should be able to:
- Discuss the basics of and the treatment options for myeloma bone disease.
- Describe the newly-available techniques for diagnostics and treatment monitoring.
- Appraise the potential of novel agents and drug combinations in early clinical trials.
- Better manage the short and long-term side effects of cellular therapies.
- Assess and interpret information about the indication, risks and benefits of novel cellular therapies, and how to obtain guidance regarding any treatment selection.